Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 491081 - 491100 out of 498602 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FX05) brentuximab vedotin | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | Pfizer,Inc. |
| USA | (L01FX05) brentuximab vedotin | ADCETRIS 50MG/10.5ML INJ | 10.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | Pfizer,Inc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | Pfizer,Inc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 20MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | Pfizer,Inc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | Pfizer,Inc. |
| USA | (L01FX13) enfortumab vedotin | PADCEV 30MG/VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | Pfizer,Inc. |
| USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
| USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
| USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
| USA | (L01XL04) tisagenlecleucel | KYMRIAH INJ,SUSP | 10-50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;Lymphoma, Large B-Cell, Diffuse | NovartisPharmaceuticalsCorporation |
| USA | (L01XL10) nadofaragene firadenovec | ADSTILADRIN SUSP,INTRAVESIC | 4X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FerringPharmaceuticals,Inc. |
| USA | (L01XL10) nadofaragene firadenovec | ADSTILADRIN SUSP,INTRAVESIC | 4X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FerringPharmaceuticals,Inc. |
| USA | (L02BB02) nilutamide (adm: O) | NILUTAMIDE 150MG TAB | 3X10 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L02BG04) letrozole (adm: O) | FEMARA TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L02BG04) letrozole (adm: O) | FEMARA TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L02BX02) degarelix (adm: P) | FIRMAGON KIT 240MG/VIL,INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | FerringPharmaceuticals,Inc. |
| USA | (L02BX02) degarelix (adm: P) | FIRMAGON KIT 240MG/VIL,INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | FerringPharmaceuticals,Inc. |
| USA | (L02BX02) degarelix (adm: P) | FIRMAGON KIT 80MG/VIL,INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | FerringPharmaceuticals,Inc. |
| USA | (L02BX02) degarelix (adm: P) | FIRMAGON KIT 80MG/VIL,INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | FerringPharmaceuticals,Inc. |
| USA | (L03AA13) pegfilgrastim (adm: P) | UDENYCA 6MG/0.6ML AUTOINJECTOR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | CoherusBiosciences,Inc. |
Pages
